Your browser doesn't support javascript.
loading
Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations.
Sakornsakolpat, Phuwanat; Prokopenko, Dmitry; Lamontagne, Maxime; Reeve, Nicola F; Guyatt, Anna L; Jackson, Victoria E; Shrine, Nick; Qiao, Dandi; Bartz, Traci M; Kim, Deog Kyeom; Lee, Mi Kyeong; Latourelle, Jeanne C; Li, Xingnan; Morrow, Jarrett D; Obeidat, Ma'en; Wyss, Annah B; Bakke, Per; Barr, R Graham; Beaty, Terri H; Belinsky, Steven A; Brusselle, Guy G; Crapo, James D; de Jong, Kim; DeMeo, Dawn L; Fingerlin, Tasha E; Gharib, Sina A; Gulsvik, Amund; Hall, Ian P; Hokanson, John E; Kim, Woo Jin; Lomas, David A; London, Stephanie J; Meyers, Deborah A; O'Connor, George T; Rennard, Stephen I; Schwartz, David A; Sliwinski, Pawel; Sparrow, David; Strachan, David P; Tal-Singer, Ruth; Tesfaigzi, Yohannes; Vestbo, Jørgen; Vonk, Judith M; Yim, Jae-Joon; Zhou, Xiaobo; Bossé, Yohan; Manichaikul, Ani; Lahousse, Lies; Silverman, Edwin K; Boezen, H Marike.
Afiliação
  • Sakornsakolpat P; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Prokopenko D; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Lamontagne M; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Reeve NF; Genetics and Aging Research Unit, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Guyatt AL; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Quebec, Canada.
  • Jackson VE; Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
  • Shrine N; Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
  • Qiao D; Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
  • Bartz TM; Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
  • Kim DK; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Lee MK; Cardiovascular Health Research Unit, University of Washington, Seattle, WA, USA.
  • Latourelle JC; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Li X; Department of Biostatistics, University of Washington, Seattle, WA, USA.
  • Morrow JD; Seoul National University College of Medicine, SMG-SNU Boramae Medical Center, Seoul, South Korea.
  • Obeidat M; Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Raleigh, NC, USA.
  • Wyss AB; Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
  • Bakke P; Department of Medicine, University of Arizona, Tucson, AZ, USA.
  • Barr RG; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Beaty TH; University of British Columbia Center for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Belinsky SA; Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Raleigh, NC, USA.
  • Brusselle GG; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Crapo JD; Department of Medicine, College of Physicians and Surgeons and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
  • de Jong K; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • DeMeo DL; Lovelace Respiratory Research Institute, Albuquerque, NM, USA.
  • Fingerlin TE; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Gharib SA; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Gulsvik A; Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Hall IP; Division of Pulmonary and Critical Care Medicine, Department of Medicine, National Jewish Health, Denver, CO, USA.
  • Hokanson JE; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.
  • Kim WJ; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands.
  • Lomas DA; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • London SJ; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Meyers DA; Center for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
  • O'Connor GT; Department of Biostatistics and Informatics, University of Colorado Denver, Aurora, CO, USA.
  • Rennard SI; Computational Medicine Core, Center for Lung Biology, UW Medicine Sleep Center, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Schwartz DA; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Sliwinski P; Division of Respiratory Medicine, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
  • Sparrow D; National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham, UK.
  • Strachan DP; Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Tal-Singer R; Department of Internal Medicine and Environmental Health Center, School of Medicine, Kangwon National University, Chuncheon, South Korea.
  • Tesfaigzi Y; UCL Respiratory, University College London, London, UK.
  • Vestbo J; Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Raleigh, NC, USA.
  • Vonk JM; Department of Medicine, University of Arizona, Tucson, AZ, USA.
  • Yim JJ; National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA.
  • Zhou X; Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
  • Bossé Y; Pulmonary, Critical Care, Sleep and Allergy Division, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Manichaikul A; Clinical Discovery Unit, AstraZeneca, Cambridge, UK.
  • Lahousse L; Department of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
  • Silverman EK; Department of Immunology, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
  • Boezen HM; 2nd Department of Respiratory Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Nat Genet ; 51(3): 494-505, 2019 03.
Article em En | MEDLINE | ID: mdl-30804561
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is the leading cause of respiratory mortality worldwide. Genetic risk loci provide new insights into disease pathogenesis. We performed a genome-wide association study in 35,735 cases and 222,076 controls from the UK Biobank and additional studies from the International COPD Genetics Consortium. We identified 82 loci associated with P < 5 × 10-8; 47 of these were previously described in association with either COPD or population-based measures of lung function. Of the remaining 35 new loci, 13 were associated with lung function in 79,055 individuals from the SpiroMeta consortium. Using gene expression and regulation data, we identified functional enrichment of COPD risk loci in lung tissue, smooth muscle, and several lung cell types. We found 14 COPD loci shared with either asthma or pulmonary fibrosis. COPD genetic risk loci clustered into groups based on associations with quantitative imaging features and comorbidities. Our analyses provide further support for the genetic susceptibility and heterogeneity of COPD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos